Literature DB >> 11318544

Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.

M Farmer1, L Hunt, M R Eichenberger, R E Petras, J E Janosky, S Galandiuk.   

Abstract

A susceptibility locus for inflammatory bowel disease (IBD) on chromosome 16 (IBD1) has been linked to Crohn's disease in genome-wide linkage studies. We performed a case-control study with two markers for this locus using leukocyte DNA from 127 Crohn's patients, 83 ulcerative colitis patients, and 74 control patients. Allele, genotype, and haplotype frequencies of the polymerase chain reaction products were determined using autoradiography. Haplotype frequencies differed for ulcerative colitis and Crohn's disease, particularly for haplotype CC (22% ulcerative colitis vs 10% Crohn's disease, P = 0.002 Chi2 = 10.0) and haplotype CD (18% Crohn's disease vs 9% ulcerative colitis, P = 0.025 Chi2 = 5.02). These data demonstrate the association of the IBD1 locus with both ulcerative colitis and Crohn's disease in a group of unrelated IBD patients. The use of such microsatellite markers when combined with others, might help distinguish ulcerative colitis from Crohn's disease in patients with ambiguous clinical and histological features.

Entities:  

Mesh:

Year:  2001        PMID: 11318544     DOI: 10.1023/a:1005623904826

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Results of the pelvic-pouch procedure in patients with Crohn's disease.

Authors:  A A Deutsch; R S McLeod; J Cullen; Z Cohen
Journal:  Dis Colon Rectum       Date:  1991-06       Impact factor: 4.585

2.  Inflammatory bowel disease: is it in the genes?

Authors:  J F Gusella; D K Podolsky
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

3.  Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.

Authors:  J D Ohmen; H Y Yang; K K Yamamoto; H Y Zhao; Y Ma; L G Bentley; Z Huang; S Gerwehr; S Pressman; C McElree; S Targan; J I Rotter; N Fischel-Ghodsian
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

4.  Genetics versus environment in inflammatory bowel disease: results of a British twin study.

Authors:  N P Thompson; R Driscoll; R E Pounder; A J Wakefield
Journal:  BMJ       Date:  1996-01-13

5.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

Review 6.  Genetic dissection of complex traits.

Authors:  E S Lander; N J Schork
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

7.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.

Authors:  A B Price
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

8.  Clinical patterns of familial inflammatory bowel disease.

Authors:  J Satsangi; C Grootscholten; H Holt; D P Jewell
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

9.  Consequences of ileal pouch-anal anastomosis for Crohn's colitis.

Authors:  N H Hyman; V W Fazio; W B Tuckson; I C Lavery
Journal:  Dis Colon Rectum       Date:  1991-08       Impact factor: 4.585

10.  Familial occurrence of inflammatory bowel disease.

Authors:  M Orholm; P Munkholm; E Langholz; O H Nielsen; T I Sørensen; V Binder
Journal:  N Engl J Med       Date:  1991-01-10       Impact factor: 91.245

View more
  1 in total

Review 1.  Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review.

Authors:  Isabelle Cleynen; Peter Jüni; Geertruida E Bekkering; Eveline Nüesch; Camila T Mendes; Stefanie Schmied; Stefan Wyder; Eliane Kellen; Peter M Villiger; Paul Rutgeerts; Séverine Vermeire; Daniel Lottaz
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.